English
Deutsch
Log In
Log in with Fraunhofer Smartcard
Password Login
Have you forgotten your password?
Research Outputs
Fundings & Projects
Researchers
Institutes
Statistics
Fraunhofer-Gesellschaft
Home
Fraunhofer-Gesellschaft
Artikel
P-019 Cytotoxic CD4+ T cells are major drivers of side effects and response after chimeric antigen receptor T cells against BCMA
Details
Full
Export
Statistics
Options
Show all metadata (technical view)
September 2024
Journal Article
Title
P-019 Cytotoxic CD4+ T cells are major drivers of side effects and response after chimeric antigen receptor T cells against BCMA
Author(s)
Fandrei, David
University Hospital Leipzig
Rade, Michael
Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Fischer, Luise
University Hospital Leipzig
Kreuz, Markus
Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Born, Patrick
University Hospital Leipzig
Boldt, Andreas
University Hospital Leipzig
Metzeler, Klaus H.
University Hospital Leipzig
Seiffert, Sabine
University Hospital Leipzig
Scolnick, Jonathan
Singleron Biotechnologies
Venkatraman, Lakshmi
Singleron Biotechnologies
Xu, Stacy
Singleron Biotechnologies
Baber, Ronny
Universität Leipzig
Wang, Song Yau
University Hospital Leipzig
Bach, Enrica
University Hospital Leipzig
Hoffmann, Sandra
University Hospital Leipzig
Herling, Marco
University Hospital Leipzig
Jentzsch, Madlen
University Hospital Leipzig
Herling, Carmen
University Hospital Leipzig
Franke, Georg-Nikolaus
University Hospital Leipzig
Köhl, Ulrike
Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Platzbecker, Uwe
University Hospital Leipzig
Vucinik, Vladan
University Hospital Leipzig
Reiche, Kristin
Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Merz, Maximilan
University Hospital Leipzig
Journal
Clinical lymphoma, myeloma & leukemia
Conference
International Myeloma Society (IMS Annual Meeting and Exposition) 2024
DOI
10.1016/S2152-2650(24)01922-0
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI